Showing results (91-100 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|October 31, 2019
Polymorphisms of NF-κB pathway genes influence adverse drug reactions of gefitinib in NSCLC patientsShuang Xin, Yuanyuan Zhao, Changzheng Wang, et al.
The Pharmacogenomics Journal|December 24, 2017
The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulationL Colàs-Campàs, J L Royo, M V Montserrat, et al.
The Pharmacogenomics Journal|December 6, 2017
Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primatesD I Staquicini, S D'Angelo, F Ferrara, et al.
The Pharmacogenomics Journal|January 17, 2019
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patientsCécile Luxembourger, Adeline Ruyssen-Witrand, Chayma Ladhari, et al.
The Pharmacogenomics Journal|January 17, 2019
Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary interventionVasilios Fragoulakis, Marina Bartsakoulia, Xando Díaz-Villamarín, et al.
The Pharmacogenomics Journal|January 17, 2019
Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients - a randomized, prospective studyTereza Ruzickova, Martin Sramek, Vojtech Kaplan, et al.
The Pharmacogenomics Journal|January 18, 2019
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patientsSarah Allegra, Jessica Cusato, Silvia De Francia, et al.
The Pharmacogenomics Journal|February 1, 2019
Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEPEleanor M Wigmore, Jonathan D Hafferty, Lynsey S Hall, et al.
The Pharmacogenomics Journal|February 5, 2019
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?Federico Nichetti, Felicia Stefania Falvella, Rosalba Miceli, et al.
The Pharmacogenomics Journal|February 7, 2019
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patientsMarzia Del Re, Saverio Cinieri, Angela Michelucci, et al.
Pageof 135